CHDCHD
US • —
$96.88
P/E
31.95
PEG
1.06
FCF Yield
—
Rev Growth YoY
+2.2% YoY
Gross Margin
45.1%
Health Score
6/10
D/E Ratio
0.55
Confidence
MEDIUM
Business Snapshot
This company operates in the consumer staples sector, broadly focused on branded consumer products. Its primary revenue-generating products include household and personal care items, a segment that typically delivers steady demand across economic cycles. The company competes with other large multinationals in the household and personal care market. As a large-cap entity, its financial scale is substantial, though TTM revenue is not provided in the available data. A defining characteristic is its consistent ability to beat earnings estimates, having done so in each of the last 4 quarters.
Financial Health
Gross margin stands at 45.1% with no prior-year figure available for comparison, making a trend assessment impossible. Net margin of 11.8% indicates a moderate level of profitability after all expenses...
Risk Assessment
- VALUATION — P/E of 31.95x is at a notable premium to the sector average of 22x, leaving limited room for error.
- TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed.
- EARNINGS QUALITY — While the company beats estimates, the disconnect between 2.2% revenue growth and 30.1% earnings growth raises questions about the sustainability of the earnings growth driver.
- INSIDER ACTIVITY — Over the last 90 days, there have been 0 insider buys and 2 insider sells, a net sell signal that management does not see current prices as a bargain....
Gross margin stands at 45.1% with no prior-year figure available for comparison, making a trend assessment impossible. Net margin of 11.8% indicates a moderate level of profitability after all expenses. The balance sheet is healthy, with a debt-to-equity ratio of 0.63x and a current ratio of 1.07x, suggesting manageable leverage and adequate short-term liquidity. Return on equity is a solid 17.4%, indicating effective capital use. Free cash flow data is unavailable, preventing an assessment of cash generation or FCF yield. The net margin and moderate debt levels suggest some capacity for reinvestment, though the lack of cash flow data limits a full health assessment.
- VALUATION — P/E of 31.95x is at a notable premium to the sector average of 22x, leaving limited room for error. - TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed. - EARNINGS QUALITY — While the company beats estimates, the disconnect between 2.2% revenue growth and 30.1% earnings growth raises questions about the sustainability of the earnings growth driver. - INSIDER ACTIVITY — Over the last 90 days, there have been 0 insider buys and 2 insider sells, a net sell signal that management does not see current prices as a bargain.
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives